Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Review Article

Nanosystems for Intranasal Delivery of Therapeutics in Psychiatric Disorders

In Press, (this is not the final "Version of Record"). Available online 10 January, 2025
Author(s): Samin Hamidi*, Ali Reza Shafiee-Kandjani and Sara Salatin
Published on: 10 January, 2025

DOI: 10.2174/0115672018336704241128101556

Price: $95

TIMBC 2025
Abstract

Due to the blood-brain barrier (BBB) and issues with oral and other traditional routes of administration, psychiatric disorders present significant challenges in getting therapeutics into the brain. The nose-to-brain pathway, also known as intranasal delivery, has shown promise in overcoming these barriers since it targets the brain directly and bypasses the BBB. This review explores nanocarriers' potential for intranasal delivery of therapeutics in the treatment of psychiatric disorders. Nanocarriers, such as polymeric nanoparticles, liposomes, and nanoemulsions, offer unique advantages for enhancing the delivery of various therapeutic agents to the brain via the intranasal route. The methodology involved conducting preliminary searches on databases such as PubMed, ScienceDirect, Web of Science, and Google Scholar using keywords related to "psychiatric disorders, intranasal delivery, nose-to-brain drug delivery, and nano formulations for intranasal delivery." This review highlights the advantages of the intranasal drug delivery pathway as a non-invasive, reliable, and efficient method for targeting the brain by bypassing the BBB. Furthermore, it discusses the application of various novel nanocarrier-based formulations, including nanoparticles, in-situ gels, nanoemulsions, hydrogels, and liposomes, for the effective intranasal delivery of therapeutics in the treatment of psychiatric conditions such as mood and anxiety disorders schizophrenia, and other illnesses.

Keywords: Nose-to-Brain drug delivery, psychiatric disorders, nano drug delivery systems, intranasal drug delivery, in situ gel.


Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy